These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. Medina I; Mills J; Leoung G; Hopewell PC; Lee B; Modin G; Benowitz N; Wofsy CB N Engl J Med; 1990 Sep; 323(12):776-82. PubMed ID: 2392131 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of trimethoprim-sulfamethoxazole in critically ill and non-critically ill AIDS patients. Chin TW; Vandenbroucke A; Fong IW Antimicrob Agents Chemother; 1995 Jan; 39(1):28-33. PubMed ID: 7695325 [TBL] [Abstract][Full Text] [Related]
6. The hydroxylamine of sulfamethoxazole and adverse reactions in patients with acquired immunodeficiency syndrome. Lee BL; Delahunty T; Safrin S Clin Pharmacol Ther; 1994 Aug; 56(2):184-9. PubMed ID: 8062495 [TBL] [Abstract][Full Text] [Related]
7. Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review. Huang YS; Yang JJ; Lee NY; Chen GJ; Ko WC; Sun HY; Hung CC Expert Rev Anti Infect Ther; 2017 Sep; 15(9):873-892. PubMed ID: 28782390 [TBL] [Abstract][Full Text] [Related]
8. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole. Fisher RG; Nageswaran S; Valentine ME; McKinney RE AIDS Patient Care STDS; 2001 May; 15(5):263-9. PubMed ID: 11530767 [TBL] [Abstract][Full Text] [Related]
9. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group. Chaisson RE; Keruly J; Richman DD; Moore RD Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373 [TBL] [Abstract][Full Text] [Related]
10. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. Hardy WD; Feinberg J; Finkelstein DM; Power ME; He W; Kaczka C; Frame PT; Holmes M; Waskin H; Fass RJ N Engl J Med; 1992 Dec; 327(26):1842-8. PubMed ID: 1448121 [TBL] [Abstract][Full Text] [Related]
11. Acute tubular necrosis associated with propylene glycol from concomitant administration of intravenous lorazepam and trimethoprim-sulfamethoxazole. Hayman M; Seidl EC; Ali M; Malik K Pharmacotherapy; 2003 Sep; 23(9):1190-4. PubMed ID: 14524651 [TBL] [Abstract][Full Text] [Related]
12. Effects of Sulfamethoxazole-Trimethoprim on Airway Colonization with Pneumocystis jirovecii. Kushima H; Ishii H; Tokimatsu I; Umeki K; Sato T; Kadota J Jpn J Infect Dis; 2016 May; 69(3):252-5. PubMed ID: 26255727 [TBL] [Abstract][Full Text] [Related]
14. Cost and benefit of secondary prophylaxis for Pneumocystis carinii pneumonia. Castellano AR; Nettleman MD JAMA; 1991 Aug; 266(6):820-4. PubMed ID: 1907671 [TBL] [Abstract][Full Text] [Related]
15. Reinstituting trimethoprim--sulfamethoxazole in patients receiving atovaquone for Pneumocystis carinii pneumonia prophylaxis. James CW; McNelis KC; Szabo S Am J Health Syst Pharm; 2003 Aug; 60(15):1572-4. PubMed ID: 12951757 [No Abstract] [Full Text] [Related]
16. Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS. Hughes W; Leoung G; Kramer F; Bozzette SA; Safrin S; Frame P; Clumeck N; Masur H; Lancaster D; Chan C N Engl J Med; 1993 May; 328(21):1521-7. PubMed ID: 8479489 [TBL] [Abstract][Full Text] [Related]
17. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial. Hibberd PL; Tolkoff-Rubin NE; Doran M; Delvecchio A; Cosimi AB; Delmonico FL; Auchincloss H; Rubin RH Online J Curr Clin Trials; 1992 Aug; Doc No 15():[4083 words; 46 paragraphs]. PubMed ID: 1343609 [TBL] [Abstract][Full Text] [Related]
18. Rapid oral desensitization to trimethoprim-sulfamethoxazole (TMP-SMZ): use in prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant to TMP-SMZ. Gluckstein D; Ruskin J Clin Infect Dis; 1995 Apr; 20(4):849-53. PubMed ID: 7795084 [TBL] [Abstract][Full Text] [Related]
19. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group. Schneider MM; Hoepelman AI; Eeftinck Schattenkerk JK; Nielsen TL; van der Graaf Y; Frissen JP; van der Ende IM; Kolsters AF; Borleffs JC N Engl J Med; 1992 Dec; 327(26):1836-41. PubMed ID: 1360145 [TBL] [Abstract][Full Text] [Related]
20. Failure of trimethoprim-sulfamethoxazole in the therapy of recurrent Pneumocystis carinii pneumonia. Mitsuyasu RT; Corwin HL; Harris AA; Trenholme GM; Levi S; Karkusis PH Am Rev Respir Dis; 1982 Jun; 125(6):762-5. PubMed ID: 6979960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]